Stifel Lowers Klaviyo (KVYO) Target to $40 from $42 on Conservative 2026 Outlook

Klaviyo, Inc. (NYSE:KVYO) is one of the best mid cap stocks to buy according to hedge funds. On November 6, Stifel lowered its price target for Klaviyo, Inc. (NYSE:KVYO) stock from $42 to $40. The firm maintained a Buy rating on the shares and explained that the price target cut was due to Klaviyo’s conservative 2026 outlook. Klaviyo expects its earnings to grow by at least 21-22% and at least one percentage point of margin improvement for 2026.

Stifel Lowers Klaviyo (KVYO) Target to $40 from $42 on Conservative 2026 Outlook

Stifel noted that Klaviyo’s efforts to expand its platform in areas such as Agents, Service, and Marketing Analytics, are “beginning to bear fruit and have laid the groundwork for multiple years of profitable growth.”

Independently of the analyst action, Klaviyo reported its Q3 2025 results on November 5 in which the quarter’s revenue was about $310.9 million, up 32% year over year. The EPS came in at $0.18, exceeding the consensus estimate of roughly $0.14.​

Management reported that the 32% year-over-year revenue growth was supported by continued expansion into mid-market and enterprise customers. International markets contributed meaningfully, with revenue from Europe, the Middle East and Africa (EMEA) and Asia-Pacific (APAC) regions growing about 43% year over year. Management highlighted this as evidence of strengthening international momentum.

Klaviyo, Inc. (NYSE:KVYO) is a cloud-based marketing automation company. It provides software that enables e-commerce businesses to analyze customer data, segment audiences, and deliver personalized email and SMS campaigns.

While we acknowledge the potential of KVYO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than KVYO and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 9 Best Gene-Editing Stocks to Buy According to Hedge Funds and 10 Best European Bank Stocks to Buy Now.

Disclosure: None. This article is originally published at Insider Monkey.